Synthetic approaches to the 2013 new drugs

被引：66
作者：
Ding, Hong X. [1 ]
Leverett, Carolyn A. [4 ]
Kyne, Robert E., Jr. [4 ]
Liu, Kevin K. -C. [2 ]
Fink, Sarah J. [3 ]
Flick, Andrew C. [4 ]
O'Donnell, Christopher J. [4 ]
机构：
[1] Pharmacodia Beijing Co Ltd, Beijing 100085, Peoples R China
[2] Lilly China Res & Dev Ctr, Shanghai 201203, Peoples R China
[3] BioDuro Co Ltd, Shanghai 200131, Peoples R China
[4] Pfizer Worldwide Res & Dev, Groton Labs, Groton, CT 06340 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2015年 / 23卷 / 09期
关键词：
Synthesis; New drug molecules; New chemical entities; Medicine; Therapeutic agents; ADENOSINE RECEPTOR ANTAGONISTS; PALLADIUM-CATALYZED SYNTHESIS; PARKINSONS-DISEASE; DOUBLE-BLIND; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; SELECTIVE INHIBITOR; DISCOVERY; 1ST; MACITENTAN;
D O I：
10.1016/j.bmc.2015.02.056
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition and also serve as leads for designing future new drugs. This annual review covers the synthesis of twenty-four NCEs that were approved for the first time in 2013 and two 2012 drugs which were not covered during the previous edition of this review. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1895 / 1922
页数：28
相关论文
共 223 条
[51]  
Eklund L., 2011, WO Patent Application, Patent No. [2011/089385, 2011089385]
[52]   Ospemifene: First Global Approval [J].
Elkinson, Shelley ;
Yang, Lily P. H. .
DRUGS, 2013, 73 (06) :605-612
[53]  
Faldt A, 2007, Patent, Patent No. [2007144005A1, 2007144005, WO 2007/144005 A1]
[54]  
Follmann M., 2012, WO Patent, Patent No. [2012028647A1, 2012028647]
[55]  
Ge C., 2007, US Pat. Appl., Patent No. [20070004920A1, 20070004920]
[56]   Olodaterol: First Global Approval [J].
Gibb, Andrew ;
Yang, Lily P. H. .
DRUGS, 2013, 73 (16) :1841-1846
[57]  
Goldstein Michael David, 2012, Patent No. 2012158764
[58]   THE YEAR'S NEW DRUGS & BIOLOGICS, 2013: PART I [J].
Graul, A. I. ;
Cruces, E. ;
Stringer, M. .
DRUGS OF TODAY, 2014, 50 (01) :51-100
[59]   Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys [J].
Grondin, R ;
Bédard, PJ ;
Tahar, AH ;
Grégoire, L ;
Mori, A ;
Kase, H .
NEUROLOGY, 1999, 52 (08) :1673-1677
[60]  
GURAM AS, 1995, ANGEW CHEM INT EDIT, V34, P1348, DOI 10.1002/anie.199513481
12345678910